Surface plasmon resonance detection of anti-cancer drug flutamide by graphitic carbon nitride/chitosan nanocomposite

利用石墨氮化碳/壳聚糖纳米复合材料进行表面等离子体共振检测抗癌药物氟他胺

阅读:1

Abstract

The g-C3N4/CS biosensor was designed, fabricated, and tested using compounds such as glucose, urine, lactose, and flutamide at a molarity of 10 µM, which could demonstrate a high sensitivity of 200 μm-1 for flutamide. Powerful effective medium theory and FDTD simulation were used to predict the most favorable mode and plasmonic properties of a graphite carbon nitride and chitosan nanocomposite. The research also explores the characteristics of surface plasmon resonance exhibited by the nanocomposite as the chitosan content is adjusted. Subsequent simulations are conducted on nanocomposites incorporating a thin layer and a modified gold structure. The intricate simulations ultimately reveal the optimal combination, tested under three different pH conditions (6.2, 7.2, and 8). In acidic conditions, the kinetic profile yielded a K(D)= 3.45 × 10(-7), surpassing the K(D) value of a thin film. The Au significantly outperformed the alternative material. The biosensor demonstrated linear behavior across a wide concentration range from 1 to 150 µM, achieving a detection limit of 120 nM with its high sensitivity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。